Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples